ASHRAF / RESEARCH SYSTEM v1.0 MY · 07 OCT 2026
ASHRAF'S RESEARCH FINDINGS
EQUITY RESEARCH · 12–18 MONTH OUTLOOK

Farm Fresh Berhad
(FFB)

Farm Fresh is evolving from a Malaysian fresh-milk company into a broader dairy and frozen-food platform. The most important 2027 earnings question is whether the investment cycle now underway converts into operating leverage: Enstek and the ice-cream platform must turn capacity into high-margin sales, the enlarged Muadzam Shah herd must increase domestic milk supply, and Cambodia, the Philippines and East Malaysia must improve their economics without consuming disproportionate capital.

FARM FRESH BERHAD KLSE: FFB · 5306 BUY / WATCH EARNINGS 12–18M FV: RM2.75
PERSONAL / PRIVATE RESEARCH JOURNAL
This report is for personal research and record-keeping only. It is not investment advice, a recommendation, an offer or solicitation to buy or sell any security . Readers should conduct their own research and seek appropriately qualified professional advice before making investment decisions.

The story is no longer
just about milk.

Farm Fresh has moved beyond the early-stage Malaysian dairy story. FY2026 revenue reached RM1.115bn and PATAMI was about RM130m. The business now has several independent growth engines: core dairy, consumer-packaged ice cream, Inside Scoop and Sin Wah, new dairy products, an enlarged domestic herd, and regional operations. The critical question is no longer whether FFB can grow revenue. It is whether the new assets can generate attractive incremental margins and cash returns.

Current price
RM1.80
07 Oct 2026 reference
12–18M FV
RM2.75
Base case
Upside
~53%
Before dividends / costs
Core view. The investment case is increasingly centred on earnings conversion. FY2026 proved the platform can exceed RM1bn of revenue, but Q1 FY2027 showed the cost of expanding distribution, staffing and financing before the new assets mature. Our base case does not require a dramatic change in consumer behaviour. It requires FFB to extract more revenue and profit from assets it has already built: Enstek, the freezer network, the enlarged Muadzam Shah herd, and regional distribution. If those assets improve utilisation and incremental margins through FY2027–28, RM2.75 remains defendable. If they merely add capacity while EPS stagnates, the valuation should fall.

What we like

  • Established Malaysian dairy brand with meaningful household recognition and distribution.
  • Vertical integration across farms, processing, cold chain and branded products reduces dependence on third-party supply.
  • Ice cream is already a material growth category, with Cream Hauz/CPG ice cream gaining traction rather than remaining a greenfield idea.
  • Enstek can lift total ice-cream production toward ~1m pieces/day, while freezer expansion and new SKUs determine whether that capacity is monetised.
  • Muadzam Shah expansion can increase domestic milk availability and reduce reliance on purchased/imported milk over time.
  • Regional operations create a longer runway, particularly Cambodia where local production should improve logistics economics.

What keeps us cautious

  • Input costs, fuel and imported milk can pressure margins before pricing catches up.
  • Enstek creates depreciation and fixed costs before utilisation reaches an economic level.
  • Ice cream is attractive but requires freezer density, sell-through and SKU productivity, not just factory capacity.
  • Regional businesses remain less proven and can absorb working capital before reaching mature margins.
  • Q1 FY2027 showed that revenue growth can coexist with lower profit when distribution, staffing and financing costs rise.
  • Placement dilution increases the share count, so absolute PAT growth must translate into per-share earnings growth.

A vertically integrated
dairy platform.

FFB's advantage is operational rather than an absolute moat. The company controls meaningful parts of the milk supply chain, combines farming with processing, cold-chain distribution and branded retail, and has repeatedly used that platform to add products. That matters because the next phase of growth is not dependent on one milk SKU. The same farms, factories, freezers, sales force and retail relationships can carry fresh milk, cultured products, butter, chocolate malt and frozen products. The strategic value is therefore in asset utilisation and distribution density, not simply brand awareness.

Brand

8.5/10

Strong Malaysian recognition, repeated brand awards and a local-dairy position that extends into adjacent categories.

Integration

9/10

Farm-to-processing integration, owned cold-chain capabilities and expanding manufacturing footprint support control over supply and product launches.

Growth

9/10

Milk, CPG ice cream, Inside Scoop, Sin Wah, butter, cultured milk, chocolate malt and regional dairy create several monetisation paths.

Why the platform matters. The most valuable part of FFB's infrastructure is the ability to launch another product into an existing route to market. The Amelia acquisition adds East Malaysia cold-chain reach, while the broader network gives FFB thousands of points at which a new product can be placed. Inside Scoop and Sin Wah also give the group exposure to different frozen-consumption occasions. This creates cross-selling potential, but it also raises the bar for capital discipline: every new factory, freezer and distribution route needs to earn an adequate return.

The next earnings leg
has several pieces.

Dairy herd
~8,000
Eventual combined Muadzam Shah capacity
Ice cream
~1m/day
Enstek + existing facilities; utilisation is the key variable
Distribution
~11k
CPG ice-cream freezers, with productivity more important than raw count
Ice-cream thesis — now a core part of the earnings model. CPG ice cream is now large enough to matter to group earnings, rather than being a speculative adjacency. FFB launched the category in August 2024, expanded production, added freezer placements and introduced formats such as cones and potong. Research coverage indicated that ice cream had already represented roughly 12% of group revenue in 2Q FY2026. The strategic attraction is that FFB can put a higher-frequency impulse product through an existing cold-chain and retail network, while Enstek provides roughly 1m pieces/day of eventual production capacity. But capacity is not revenue: the investment case depends on sell-through, sales per freezer, mix and utilisation being high enough to cover the new facility's depreciation and operating costs. The ZUS Coffee collaboration is useful evidence of this distribution model in practice. Co-branded Spanish Latte, Café Mocha and Café Latte ice creams were launched through selected FamilyMart outlets, showing how FFB can borrow an established consumer brand and retail channel to create trial and reach. We therefore treat partnerships as a demand-generation tool, not as a thesis on their own.

What should drive FY27–28

  • Muadzam Shah herd expansion increasing domestic fresh-milk production, with meaningful benefits expected to build from 2027 as the new cows mature.
  • Enstek ramp-up taking total ice-cream capacity toward ~1m pieces/day and spreading fixed manufacturing costs over a larger sales base.
  • Freezer expansion, better sales per freezer and broader SKU coverage converting capacity into sell-through.
  • New ice-cream formats including cones and potong, plus co-branded products such as the ZUS Coffee collaboration, increasing consumer trial and shelf relevance.
  • Regional localisation, especially Cambodia, reducing logistics and clearing costs while widening the product range.
  • HORECA traction in fresh milk, butter and cultured products creating additional routes to monetise the dairy platform.

What would prove the thesis

  • Ice-cream revenue continues to grow faster than the group, with new products and channels increasing sales per freezer rather than merely freezer count.
  • Gross margin stabilises or improves despite higher distribution and input costs.
  • Enstek utilisation rises enough for incremental gross profit to exceed the depreciation and operating costs of the new facility.
  • Muadzam Shah milk output begins reducing purchased-milk dependence and/or improves product margins.
  • Operating cash flow improves after the current capex and working-capital cycle.
  • EPS growth remains healthy after the 96.5m-share private placement dilution.

Cambodia and the Philippines
are options, not the base case.

We give regional operations strategic value, but we do not let them carry the base-case valuation yet. The important distinction is between revenue growth and local economics. Cambodia is the more advanced case: monthly sales have exceeded RM4m, a local partner is developing a large Phnom Penh processing facility, and management is investing in local manufacturing to reduce logistics costs and improve responsiveness. The Philippines is earlier and should remain an option value until distribution density and margins become visible. Singapore remains an export market, while Cambodia's sales momentum shows why local production can become more important than simply exporting from Malaysia. We therefore want evidence of gross-margin improvement, lower cost-to-serve and operating leverage before assigning a material regional earnings multiple.

Malaysia

CORE

The proven earnings engine. Most of the valuation should still be supported here.

Cambodia

OPTION

Local production can improve cost-to-serve and support Indochina expansion if utilisation scales.

Philippines

OPTION

Large addressable market, but execution and distribution density remain the main variables.

Valuation discipline. We do not assign a heroic terminal value to regional operations. They are upside to the core Malaysian earnings engine until local profitability becomes visible.

Growth has been real.
Now returns must catch up.

FFB has compounded revenue rapidly, but FY2027 begins with a clear earnings-conversion test. Q1 revenue rose 17.6% YoY to RM306.4m, while PAT fell to RM26.8m from RM33.2m. Distribution, staffing and financing costs absorbed much of the revenue gain, while new capacity is still carrying depreciation before reaching mature utilisation. Gross profit was RM93.6m, implying a margin of about 30.5%, below the FY2026 level. This is not yet evidence that the growth thesis is broken, but it is evidence that scale alone is insufficient. The next few quarters need to show that ice-cream volume, domestic milk supply, pricing and regional localisation can turn the current fixed-cost investment into incremental profit and cash flow.

RM m FY2022A FY2023A FY2024A FY2025A FY2026A FY2027 Q1
Revenue 501.9 629.7 810.4 981.2 1,115.4 306.4
PAT 78.6 49.9 63.3 107.3 130.4 26.8
PATAMI 79.9 50.1 63.5 106.4 130.0 26.8
Gross profit 136.3 149.7 216.0 315.2 366.7 93.6

Figures shown here are the figures used in the current FFB research framework. Forward estimates are Ashraf's assumptions, not company guidance.

What the numbers are telling us. FY2026 delivered RM1.115bn revenue and about RM130m PATAMI. Q1 FY2027 then showed the other side of the expansion cycle: revenue growth remained strong, but profit fell. Management is responding through selective pricing, alternative sourcing, efficiency measures and the conversion of Muadzam Shah's fuel system to LNG, which is expected to save roughly RM4–5m annually. The critical question is whether these savings and the new growth engines become large enough to reverse the current cost drag.

FY2027–28 is where
the investment case gets tested.

Base case · controlled growth

Revenue continued double-digit growth
PATAMI continues compounding
Gross margin broadly stable
Malaysia remains the earnings anchor
Regional gradual contribution

Our base case assumes the current expansion starts converting into earnings during FY2027–28 without requiring heroic assumptions. We do not need a huge market-share win. We need the existing platform to become more productive. That means Enstek filling capacity progressively, freezer sales rising faster than freezer count, new ice-cream SKUs improving mix, the Muadzam Shah herd adding domestic milk supply, and Cambodia reducing cost-to-serve as local production comes online. The key is that operating profit grows faster than depreciation, distribution, staffing and financing costs.

Upside case · operating leverage

Revenue accelerates
Ice cream becomes a larger, higher-margin engine
ZUS / partnerships increase product trial and reach
Herd expansion adds domestic milk supply from 2027
Regional moves toward better unit economics
FCF improves as capex intensity normalises

The bull case requires a visible change in the earnings profile. Enstek needs to move from commissioning and depreciation drag into high utilisation; the freezer network needs materially higher sales per point; ZUS and other partnerships need to demonstrate repeat demand rather than one-off launches; and the enlarged Muadzam Shah herd needs to contribute meaningful fresh milk volume. Cambodia then becomes upside if local manufacturing improves margins and scales beyond the current export model. Only when those pieces appear in reported EBIT, EPS and operating cash flow would we justify a higher multiple.

ashraf@research:~$ ./check-thesis FFB

Revenue growth >10% → HEALTHY
Gross margin STABLE → REQUIRED
Incremental EBIT POSITIVE → REQUIRED
Regional PAT RAMPING → UPSIDE
Free cash flow IMPROVING → REQUIRED
ROIC RISING → REQUIRED

status: WATCH EARNINGS CONVERSION

RM2.75 is a growth target,
not a moonshot.

Our 12–18 month fair value of RM2.75 reflects the quality of the platform and a reasonable earnings-growth outcome, rather than assuming a speculative terminal value. The valuation case rests on FY2027–28 earnings recovery, particularly the monetisation of the ice-cream platform and improved utilisation of recent capacity additions. The RM2.75 figure should be compressed if earnings conversion fails.

Current price
RM1.80
07 Oct 2026
Base FV
RM2.75
12–18 months
Upside
~53%
Before dividends / costs
Valuation discipline. The stock deserves a premium to mature dairy names because its growth runway is longer. It does not deserve an unlimited premium. If earnings growth falls materially below our base case, the fair value should be compressed rather than defended.
Scenario Fair value What must happen Risk / reward
Bear RM1.55–1.75 Growth slows, margins compress, regional expansion disappoints Downside
Base RM2.75 Domestic growth + ice-cream ramp + herd contribution + steady/improving margins Attractive
Bull RM3.20–3.40 Ice cream scales rapidly + ZUS/brand partnerships broaden reach + regional scale + FCF improvement High upside

The biggest risk is not
lack of demand. It is poor capital returns.

Primary risks

  • Input costs: milk powder, packaging, energy, fuel and agricultural costs can pressure margins before pricing or sourcing actions catch up.
  • Capex intensity: Enstek, Muadzam Shah, Cambodia and other expansion projects consume cash and add depreciation before utilisation reaches mature levels.
  • Execution: factories and distribution networks can destroy returns if utilisation or sales productivity remains low.
  • Competition: multinational dairy/ice-cream brands remain powerful, while FFB's newer CPG ice-cream business must win freezer space and repeat purchase.
  • Valuation: the stock can derate sharply if investors stop believing that the expansion cycle will restore earnings growth.

Hard thesis killers

1. Revenue growth continues but incremental margins deteriorate materially because distribution, staffing and depreciation absorb the gross-profit gain.
2. Enstek and/or the expanded herd remain underutilised long enough that depreciation and financing costs overwhelm their contribution.
3. Regional expansion requires repeated capital injections without a credible path to positive operating leverage.
4. Free cash flow remains structurally weak and per-share earnings fail to grow after the private-placement dilution.

What I would actually
check every quarter.

Revenue growth
Does the platform keep scaling?
>10%
Gross margin
Pricing versus input inflation
STABLE
Incremental EBIT
Does new capacity earn?
POSITIVE
Ice cream
Enstek utilisation, sales per freezer, new SKUs and category mix
RISING
Domestic milk supply
Muadzam Shah herd maturity / milk output
FROM 2027
Regional operations
Cambodia / Philippines economics
RAMPING
Operating cash flow
Earnings quality
IMPROVING
ROIC
Return on the expansion cycle
RISING
The most important signal is earnings conversion . If revenue grows but ice-cream utilisation, gross margin, cash flow and ROIC do not follow, the expansion narrative deserves a lower multiple. We particularly want to see the new capacity become visible in reported profit rather than only in management commentary.

FFB is a bet on
the next phase of scale.

At RM1.80, the risk/reward is becoming more interesting, but the stock is still an earnings-conversion story rather than a fully proven turnaround. The company has already built a meaningful dairy and ice-cream platform. The next question is whether Enstek, the larger herd, distribution expansion and regional localisation can lift PAT faster than depreciation, finance costs and working capital.

Overall research score
8.3 / 10
Strong growth platform, but FY2027 earnings conversion remains unproven
Base fair value
RM2.75
12–18 months
Bull-case value
RM3.20–3.40
12–18M bull case

Scorecard

Brand / consumer position
8.5/10
Vertical integration
9.0/10
Domestic growth
8.8/10
Ice cream opportunity
9.0/10
Distribution / freezer platform
8.5/10
Regional optionality
8.0/10
Management / execution
8.0/10
Balance sheet
7.2/10
Cash-flow quality
7.0/10
Capital allocation
7.7/10
Valuation
7.8/10
Bottom line: FFB deserves to be treated as a quality growth platform, but the premium must now be earned through reported earnings. The most important 2027 catalysts are Enstek utilisation, freezer productivity, ZUS and other product partnerships, the maturation of the enlarged Muadzam Shah herd, and improving regional economics. RM2.75 is achievable without requiring a heroic market-share assumption; RM3.20+ requires clear operating leverage, stronger per-share earnings and evidence that the expansion cycle is generating attractive returns.
≤RM1.70 · STRONG BUY RM1.70–2.00 · BUY / ACCUMULATE RM2.00–2.50 · HOLD / WAIT FOR EARNINGS >RM3.00 · NEED FASTER EARNINGS GROWTH

What is reported, and what is ours.

Reported / researched

  • FY2026 revenue of approximately RM1.115bn and PATAMI of approximately RM130m.
  • Q1 FY2027 revenue RM306.4m and PAT RM26.8m, with revenue +17.6% YoY but PAT down 18.2% YoY.
  • FY2026 gross profit approximately RM366.7m; Q1 FY2027 gross profit RM93.6m.
  • CPG ice cream launched in August 2024 and already became a material growth category; 2Q FY2026 ice cream was reported at about 12% of group revenue by research coverage.
  • Enstek designed for approximately one million ice-cream pieces/day, alongside expanded Taiping capacity and an expanding freezer network.
  • Muadzam Shah expansion increases eventual combined capacity toward roughly 8,000 cows.
  • Inside Scoop, Sin Wah and Cream Hauz/CPG ice cream provide complementary positions across premium, traditional and mass-market frozen products.
  • Recent ZUS Coffee co-branded ice cream launched through selected FamilyMart outlets, demonstrating the ability to use partnerships for product innovation and distribution.
  • Cambodia sales have grown meaningfully and local manufacturing is intended to improve logistics economics.
  • Amelia acquisition adds Sabah cold-chain infrastructure, ~3,500 freezers/distribution points and 25 owned trucks.
  • Private placement completed in September 2026: 96.46m new shares at RM1.95, raising RM188.1m gross.

Our framework

  • Continued double-digit medium-term revenue growth, but with stronger profit conversion than Q1 FY2027.
  • Enstek and ice-cream distribution scale sufficiently to create operating leverage.
  • Freezer productivity improves as new SKUs and partnerships increase sell-through.
  • Muadzam Shah herd expansion contributes meaningfully to domestic milk supply from 2027.
  • Cambodia and the Philippines move toward better unit economics without requiring repeated capital injections.
  • Private-placement dilution is incorporated into per-share earnings expectations.
  • RM2.75 12–18 month fair value remains the base research target, subject to earnings confirmation.
  • Scenario probabilities and forward earnings assumptions remain our own research assumptions, not company guidance.

The thesis above is the primary research. This final section only separates reported company information from our assumptions so the reader can see where judgement enters the valuation. It is not intended as a substitute for the analysis in Sections 01–10.

research note:

This is an independent research framework, not investment advice.
Forecasts can be wrong. The dashboard exists to make that visible.
The thesis should be updated when the numbers change, not defended because
the story is attractive.

status: alive · re-evaluate when the numbers change